Clinical Research
Copyright ©The Author(s) 2004.
World J Gastroenterol. Sep 1, 2004; 10(17): 2529-2534
Published online Sep 1, 2004. doi: 10.3748/wjg.v10.i17.2529
Figure 2
Figure 2 Study of proliferative activity, assessed by PCNA immunostaining. A significant reduction of cellular proliferation were observed in rats with compensated cirrhosis. This reduction was normalized in IGF-1 treated cirrhotic group (CI + IGF). (× 200 magnification, in the three pictures).